That multiple COVID-19 vaccines might soon be found safe and effective and ready to be distributed to millions of people seems to have rattled more than a few people. That must be why we are starting to see some of these folks pushing the idea that these vaccines trials have already failed, even though they haven’t even finished yet.
But why do they want the COVID-19 trials to fail?
Beware of Folks Pushing the Idea That COVID-19 Vaccine Trials Will Fail from the Start
Or maybe a better question might be why do they want you to think we won’t have safe and effective COVID-19 vaccines?
“When a vaccine comes into usage, we might therefore not know if it has any important effects. We should not be too optimistic about what a corona vaccine might accomplish if we compare with the influenza vaccines, which do not have documented effects on transmission, hospital admission, serious disease or death. We will know very little about the harms of the vaccine, and nothing about the rare but serious harms.”
Peter C Gøtzsche on The coronavirus pandemic: can we handle such epidemics better?
Why do they want you to think they will fail?
“But the protocols should heighten anxiety rather than alleviate it. A close reading suggests the clinical trials have been designed to ensure the greatest possible success for these candidates — and that could overstate their effectiveness.”
William Haseltine on Beware of covid-19 vaccine trials designed to succeed from the start
Their main concern?
They don’t think that the initial COVID-19 vaccine trials can prove that the vaccines can prevent severe disease.
Should that be a concern right now?
“The justification of a mild, more common, endpoint as the primary endpoint in vaccine trials would be predicated on the assumption that the benefit of the vaccine on the selected endpoint is reasonably likely to predict clinical benefit for cases of microcephaly or other severe complications.”
Considerations for the design of vaccine efficacy trials during public health emergencies
Maybe not, when you consider that it takes longer to do trials that focus on severe cases.
“Study endpoints should be selected to support the broader intended use of a vaccine and should reflect the public health burden of interest.”
Considerations for the design of vaccine efficacy trials during public health emergencies
But if a COVID-19 vaccine is shown to be safe and effective at preventing “any occurrence of covid-19, not necessarily a severe case,” should we wait until it is shown to also prevent severe cases as the death count continues to rise?
“Typically, the more severe a disease is, the better chance a vaccine has of preventing that disease. So, a vaccine that’s 50% effective against mild COVID disease—which might be the endpoint that’s measured in a clinical trial, or any evidence of COVID infection with any symptom, which is how a lot of trials are designed—might be more effective against severe disease.”
A Top Vaccine Expert Answers Important Questions About a COVID-19 Vaccine
That doesn’t mean we want a rushed vaccine that isn’t safe or that doesn’t work, but we do want things to move along much faster than they usually do.
We need a safe and effective COVID-19 vaccine now.
“The second characteristic of denial is the use of fake experts. These are often credentialed individuals who hold views outside the broader scientific consensus.”
Believers need to be as prepared for a Covid-19 vaccine as anti-vaxxers are against it
We don’t need folks like Peter Doshi and Peter C Gøtzsche and others, who have been critical of other vaccines (shouldn’t they have mentioned that in their articles???), scaring everyone about COVID-19 vaccines that haven’t even been approved yet.
More on the COVID-19 Vaccine Trials
- I’m Not Anti-Vaccine, I Just Don’t Believe in Flu Shots
- I’m Not Anti-Vaccine, I Just Don’t Believe in the HPV Vaccine
- Who Dies from the Flu?
- Why Does the BMJ Post Anti-Vaccine Propaganda?
- Did the BMJ Have a Debate About the Risk of Dying from the MMR Vaccine Vs Measles?
- Are There Any Long-Term Studies On Vaccine Safety?
- What Are the Benefits of the Flu Shot?
- QAnon Vaccine Conspiracy Theories
- What Do Anti-Maskers Have in Common With Anti-Vaxxers?
- Twindemic – Hype or Hazard
- Design of vaccine efficacy trials during public health emergencies
- A Top Vaccine Expert Answers Important Questions About a COVID-19 Vaccine
- COVID-19 vaccine trials should seek worthwhile efficacy
- Believers need to be as prepared for a Covid-19 vaccine as anti-vaxxers are against it
- Scientists are racing to create a COVID-19 vaccine. Anti-vaxxers may soon complicate their efforts.
- When a Vaccine Arrives, People Will Ignore the Anti-Vaxxers
- Peter Doshi is at it again with the anti-vaccine stuff
- Peter Doshi, vaccine denier, sees a conspiracy about VAERS
- The zombie anti-vaccine lie–Peter Doshi and the appeal to authority
- Crisis or Crossroads at the Cochrane Collaboration?
- Peter Gøtzsche and the antivaxers
My, and many others, reluctance has everything to do with the safety, and nothing to do with; “They don’t think that the initial COVID-19 vaccine trials can prove that the vaccines can prevent severe disease.”
“Their main concern?” Long term safety of us and our children’s children. We have NO IDEA what affect the new vaccine, whatever it is, will have on our bodies 10, 15, 40 years down the road. I have a hunch that autism rates won’t go down with the vaccine.